Daniël W. Hommes

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

Geert D’Haens, Filip Baert, Gert Van Assche et al. · The Lancet · 2008 · 1.2K citations

Autoimmune Disease, Immunosuppressive Therapy, Immunology +5

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 883 citations

Gastroenterology, Tight Control Management, Clinical Gastroenterology +3

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Walter Reinisch, William J. Sandborn, Daniël W. Hommes et al. · Gut · 2011 · 874 citations · Full text

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Filip Baert, Liesbeth Moortgat, Gert Van Assche et al. · Gastroenterology · 2009 · 821 citations · Full text

Inflammation, Mucosal Immunology, Immunology +6

A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

Henri Braat, Pieter Rottiers, Daniël W. Hommes et al. · Clinical Gastroenterology and Hepatology · 2006 · 760 citations

Inflammation, Chronic Inflammatory Diseases, Microbial Disease +8